Comparison of the effects of immediate‐release omeprazole powder for oral suspension and pantoprazole delayed‐release tablets on nocturnal acid breakthrough in patients with symptomatic gastro‐oesophageal reflux disease
Authors:
- 9 June 2005
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 21 (12) , 1467-1474
Abstract
Summary: Background : Many patients treated with a proton‐pump inhibitor for gastro‐oesophageal reflux disease or erosive oesophagitis still have substantial night‐time gastric acidity. A previous trial of a new immediate‐release omeprazole oral suspension suggested that nocturnal gastric acidity could be more effectively controlled with a bedtime dose of immediate‐release omeprazole than with a delayed‐release proton‐pump inhibitor administered before dinner or at bedtime.Aim : To compare the ability of immediate‐release omeprazole with pantoprazole to control nocturnal gastric acidity, when they were dosed once daily and twice daily.Methods : Thirty‐six patients with nocturnal gastro‐oesophageal reflux disease symptoms received immediate‐release omeprazole and pantoprazole in this open‐label, randomized‐crossover trial. Median gastric pH, the percentage of time with gastric pH > 4 and the percentage of patients with nocturnal acid breakthrough, were evaluated with 24‐h pH monitoring.Results : Repeated once daily (bedtime) dosing with immediate‐release omeprazole suspension produced significantly better nocturnal gastric acid control than repeated once daily (predinner) or twice daily (prebreakfast and bedtime) dosing with pantoprazole delayed‐release tablets (median pH: 4.7 vs. 2.0 and 1.7; percentage of time pH > 4: 55 vs. 27 and 34; nocturnal acid breakthrough: 53 vs. 78 and 75). Twice daily dosing (prebreakfast and bedtime) with immediate‐release omeprazole 20 and 40 mg achieved the best night‐time control of gastric acidity. Repeated once daily bedtime dosing with immediate‐release omeprazole 40 mg and twice daily dosing with pantoprazole 40 mg gave similar 24‐h pH control. No safety issues were associated with either drug in this trial.Conclusions : Dosed once daily at bedtime, immediate‐release omeprazole reduced nocturnal gastric acidity to a degree not observed with once daily dosing of delayed‐release proton‐pump inhibitors.Keywords
This publication has 17 references indexed in Scilit:
- Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patientsCritical Care Medicine, 2005
- Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology, 2005
- Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthroughAlimentary Pharmacology & Therapeutics, 2004
- Nighttime Heartburn Is An Under-Appreciated Clinical Problem That Impacts Sleep and Daytime Function: The Results of A Gallup Survey Conducted on Behalf of The American Gastroenterological AssociationAmerican Journal of Gastroenterology, 2003
- Problems related to acid rebound and tachyphylaxisBest Practice & Research Clinical Gastroenterology, 2001
- Gastro‐oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 1998
- Lansoprazole 30mg versus omeprazole 40mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial)European Journal of Gastroenterology & Hepatology, 1996
- Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?Gastroenterology, 1994
- Evaluation of Omeprazole in Reflux OesophagitisScandinavian Journal of Gastroenterology, 1989
- Clinical presentation of patients with "dyspepsia". Detailed symptomatic study of 360 patients.Gut, 1978